William A. Frazier
Signal active
Co-founder
Contact Information
Social
Primary Organization
Arch Oncology
Founded
2006
Employees
11-50
Industry
Biotechnology, Medical, Therapeutics, Oncology
Bio
William Frazier, Ph.D. co-founded the Company based on research from his laboratory and from the National Institutes of Health. He discovered that CD47 is a receptor for thrombospondin-1 and has been a leader in the field of CD47-mediated signaling pathways, contributing to over 140 publications. Dr. Frazier is a professor of Biochemistry, Molecular Biophysics, and Cell Biology at Washington University School of Medicine.
Location
St Louis, Missouri, United States, North America
Jobs history
0
N/A
Educations
1
N/A
Profile Resume
William A. Frazier is the Co-founder at Arch Oncology, based in United States, North America. With a background in Biotechnology, William A. Frazier has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.